Please login to the form below

Not currently logged in

Excellence in Healthcare Professional Education and Support Programmes

Sponsored by

Back to Results


INSPIRE: Improving Outcomes in Paediatric Cardiology

by AbbVie with support from Lucid Group

Summary of work

Babies with congenital heart disease (CHD) present a wide range of anatomical abnormalities; uniting the diverse pathology is a risk of life-threatening complications and a paucity of research and investment. Without big funding, there are few multinational trials and international congresses that generate robust data and showcase results: there is limited infrastructure to enable paediatric cardiologists across the world to connect. This lack of connection hampers collaborative research, and honest expertise and experience sharing, impeding advances in quality of care.

INSPIRE was established to drive implementation of a core set of clinical behaviours underpinning optimal clinical management of babies with CHD. INSPIRE (International Specialist Paediatric Cardiology Care) mapped key components and behaviours that contribute to optimal care and worked with global leaders to develop small-group, practical, in-clinic training blending traditional medical education and peer-to-peer sharing in an open, honest and safe environment. A flexible approach addressed variations in global clinic models/challenges and a tailored agenda addressed delegates’ barriers. Four months later, 100% of delegates were using INSPIRE learnings to inform their clinical practice with 82% noting advances to their clinical management strategies aligned to the core behaviours. Together INSPIRE has helped up to 7,700 vulnerable paediatric patients per year receive improved care.

Judges' comments

The objectives from AbbVie and Lucid were well thought through. There was a very clear strategy and great feedback from participants. There was evidence of deep market and customer insight, as well as proof of improved health outcomes. The patient outcomes showed good, proper benefits, with 7,700 patients receiving approved care.


Angels Initiative - by Boehringer Ingelheim International GmbH

Highly commended

CLEAR HORIZONS: A New Era of Psoriasis Care - by AbbVie with support from Lucid Group

Highly commended

Academy for Science and Continuing Medical Education in Diabetes (ASCEND) - by Novo Nordisk [unrestricted grant provider] with support from International Medical Press, a Nucleus Global agency


INSPIRE: Improving Outcomes in Paediatric Cardiology - by AbbVie with support from Lucid Group

4 Sites: Navigating the Course Ahead - by AbbVie with support from Sciterion

Advanced Communication Training for Heart Failure Nurses - by Novartis with support from Aurora

Key dates

Entry deadline 26 August 2022
Extended entry deadline 2 September 2022*
*additional fee applies
Judging Day 6 October 2022
Company/Team of the Year Interviews 21 October 2022
PMEA Event 23 November 2022